309747-94-2 Usage
Chemical class
Piperidine derivatives
A class of chemical compounds containing a piperidine ring.
Structure
Piperidine ring
A six-membered heterocyclic ring with one nitrogen atom and five carbon atoms.
Protecting group
BOC (tert-butyloxycarbonyl)
A bulky group attached to the nitrogen atom of the piperidine ring, protecting it from unwanted reactions.
Substituent
2-fluoro-phenylamino-methyl group
A functional group containing a 2-fluorophenyl ring and an aminomethyl moiety attached to one of the carbon atoms of the piperidine ring.
Potential applications
Medicinal chemistry and pharmaceutical research
Due to the diverse biological activities exhibited by piperidine derivatives, 1-BOC-3-[(2-FLUORO-PHENYLAMINO)-METHYL]-PIPERIDINE may have therapeutic potential.
Reactivity manipulation
BOC protecting group
The presence of the BOC group allows for control over the compound's reactivity, enabling selective reactions and synthesis.
Pharmacological properties
Fluorophenyl group
The 2-fluorophenyl group may contribute to the compound's pharmacological properties, affecting its interactions with biological targets.
Synthesis building block
Novel bioactive molecules
1-BOC-3-[(2-FLUORO-PHENYLAMINO)-METHYL]-PIPERIDINE can be used as a building block in the synthesis of new bioactive molecules with therapeutic potential.
Check Digit Verification of cas no
The CAS Registry Mumber 309747-94-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,0,9,7,4 and 7 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 309747-94:
(8*3)+(7*0)+(6*9)+(5*7)+(4*4)+(3*7)+(2*9)+(1*4)=172
172 % 10 = 2
So 309747-94-2 is a valid CAS Registry Number.
309747-94-2Relevant academic research and scientific papers
Heterocyclic analgesic compounds and methods of use thereof
-
, (2008/06/13)
One aspect of the present invention relates to novel heterocyclic compounds. A second aspect of the present invention relates to the use of the novel heterocyclic compounds as ligands for various cellular receptors, including opiate receptors, other G-protein-coupled receptors, and ion channels. An additional aspect of the present invention relates to the use of the novel heterocyclic compounds as analgesics.
Heterocyclic analgesic compounds and methods of use thereof
-
, (2008/06/13)
One aspect of the present invention relates to novel heterocyclic compounds. A second aspect of the present invention relates to the use of the novel heterocyclic compounds as ligands for various cellular receptors, including opiate receptors, other G-protein-coupled receptors, and ion channels. An additional aspect of the present invention relates to the use of the novel heterocyclic compounds as analgesics.
Heterocyclic analgesic compounds and methods of use thereof
-
, (2008/06/13)
One aspect of the present invention relates to novel heterocyclic compounds. A second aspect of the present invention relates to the use of the novel heterocyclic compounds as ligands for various cellular receptors, including opiate receptors, other G-protein-coupled receptors, and ion channels. An additional aspect of the present invention relates to the use of the novel heterocyclic compounds as analgesics.
